Universal Biosensors, Inc.

As of June 30, 2025, Universal Biosensors, Inc. has 298.07M shares outstanding.

These figures are as of June 30, 2025. The price-to-sales ratio is 1.75, and the price-to-book ratio stands at 1.47.

These figures are as of June 30, 2025. The EV/Sales ratio of 1.90 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of June 30, 2025, Universal Biosensors, Inc. maintains a current ratio of 1.90, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 43.03, indicating elevated leverage, while an interest coverage ratio of -1,723.14 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2025, Universal Biosensors, Inc. posted a negative return on equity (ROE) of -110.97, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -72.76, reflecting losses generated across the asset base. Inventory turnover of 1.00 indicates how many times Universal Biosensors, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2025, Universal Biosensors, Inc. posted a gross margin of 26.73, reflecting its pricing power and cost economics. The operating margin of -298.73 and net profit margin of -293.32 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2025. Free cash flow yield is negative at -121.09: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 11.42, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Universal Biosensors, Inc. shareholders.

Universal Biosensors, Inc.'s most recent stock split took place on April 15, 2024 with a 1000:1059 split ratio.

As of June 30, 2025, Universal Biosensors, Inc. has an Altman Z-Score of -14.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.